More than half of U.S. adults might be candidates for Ozempic
More than half of all American adults, almost 137 million people, could be candidates for the blockbuster GLP-1 drug ...
SHINE9h
Losing weight is such a slog. Will Wegovy be a silver bullet for China?
Danish pharmaceutical company Novo Nordisk announced last weekend that Wegovy, the weight-loss version of the company's ...
NBC Los Angeles16h
FDA weighs in on diet drug shortage, creating more confusion about compounding
As millions patients struggled to fill their prescriptions for the new weight loss drugs, many have turned to compounded copies.
MedPage Today21h
Over 50% of U.S. Adults Qualify for Ozempic, Wegovy
More than half of all adults in the U.S. are eligible for semaglutide (Ozempic, Wegovy, Rybelsus), researchers estimated.